A phase II, open label, randomized controlled trial of nivolumab plus ipilimumab with stereotactic radiotherapy versus ipilimumab plus nivolumab alone in patients with melanoma brain metastases (ABC -X Trial).

被引：11
|
作者：
Gonzalez, Maria
Hong, Angela M.
Carlino, Matteo S.
Atkinson, Victoria
Wang, Wei
Lo, Serigne
Brown, Michael Paul
Foote, Matthew C.
Pinkham, Mark B.
Le, Hien
Roos, Daniel E.
Osorio, Monica
Haghighi, Neda
Kok, David
Postow, Michael A.
McArthur, Grant A.
Menzies, Alexander M.
Long, Georgina V.
机构：
[1] Melanoma Inst Australia, Sydney, NSW, Australia
[2] Univ Sydney, Chris OBrien Lifehouse, Melanoma Inst Australia, Sydney, NSW, Australia
[3] Univ Sydney, Westmead Hosp, Sydney, NSW, Australia
[4] Univ Sydney, Blacktown Hosp, Melanoma Inst Australia, Sydney, NSW, Australia
[5] Univ Queensland, Gallipoli Med Res Fdn, Princess Alexandra Hosp, Woolloongabba, Qld, Australia
[6] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
[7] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[8] Royal Adelaide Hosp, Adelaide, SA, Australia
[9] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia
[10] Univ Queensland, Queensland Univ Technol, Gamma Knife Ctr Queensland, Princess Alexandra Hosp, Woolloongabba, Qld, Australia
[11] Univ Adelaide, Royal Adelaide Hosp, Adelaide, SA, Australia
[12] Melanoma Inst Australia, Sydney, NSW, Australia
[13] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[15] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[16] Univ Sydney, Melanoma Inst Australia, Royal North Shore Hosp, Sydney, NSW, Australia
[17] Royal North Shore Hosp, Sydney, NSW, Australia
[18] Mater Hosp, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.TPS9600
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9600
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
    Schoenfeld, Jonathan D.
    Hanna, Glenn J.
    Jo, Vickie Y.
    Rawal, Bhupendra
    Chen, Yu-Hui
    Catalano, Paul S.
    Lako, Ana
    Ciantra, Zoe
    Weirather, Jason L.
    Criscitiello, Shana
    Luoma, Adrienne
    Chau, Nicole
    Lorch, Jochen
    Kass, Jason I.
    Annino, Donald
    Goguen, Laura
    Desai, Anupam
    Ross, Brendan
    Shah, Hina J.
    Jacene, Heather A.
    Margalit, Danielle N.
    Tishler, Roy B.
    Wucherpfennig, Kai W.
    Rodig, Scott J.
    Uppaluri, Ravindra
    Haddad, Robert I.
    JAMA ONCOLOGY, 2020, 6 (10) : 1563 - 1570
  • [22] Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma
    Kraehenbuehl, Lukas
    Holland, Aliya
    Armstrong, Emma
    O'Shea, Sirinya
    Mangarin, Levi
    Chekalil, Sara
    Johnston, Amanda
    Bomalaski, John S.
    Erinjeri, Joseph P.
    Barker, Christopher A.
    Francis, Jasmine H.
    Wolchok, Jedd D.
    Merghoub, Taha
    Shoushtari, Alexander N.
    CANCERS, 2022, 14 (11)
  • [23] Safety and Clinical Outcomes of Ipilimumab and Nivolumab Plus Concurrent Stereotactic Radiosurgery for Brain Metastases
    Johnson, C. B.
    Postow, M. A.
    Chapman, P.
    Wolchok, J. D.
    Brennan, C. W.
    Tabar, V. S.
    Chan, T. A.
    Yamada, Y.
    Yang, T. J.
    Beal, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E228 - E228
  • [24] Ipilimumab in a Phase II trial of melanoma patients with brain metastases
    Margolin, Kim
    ONCOIMMUNOLOGY, 2012, 1 (07) : 1197 - 1199
  • [25] Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial (vol 19, pg 1480, 2018)
    Hodi, F. S.
    Chiarion-Sileni, V
    Gonzalez, R.
    LANCET ONCOLOGY, 2018, 19 (11) : E581 - E581
  • [26] Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.
    Lucas, Minke W.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Menzies, Alexander M.
    Lopez-Yurda, Marta I.
    van Akkooi, Alexander Christopher Jonathan
    van Houdt, Winan J.
    Saw, Robyn P. M.
    Torres Acosta, Alex
    Lo, Serigne N.
    Hospers, Geke
    Carlino, Matteo S.
    de Groot, Jan Willem
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn
    Rutkowski, Piotr
    Sandhu, Shahneen
    van der Veldt, Astrid Aplonia Maria
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL)
  • [27] Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma
    Long, Georgina V.
    Larkin, James
    Schadendorf, Dirk
    Grob, Jean-Jacques
    Lao, Christopher D.
    Marquez-Rodas, Ivan
    Wagstaff, John
    Lebbe, Celeste
    Pigozzo, Jacopo
    Robert, Caroline
    Ascierto, Paolo A.
    Atkinson, Victoria
    Postow, Michael A.
    Atkins, Michael B.
    Sznol, Mario
    Callahan, Margaret K.
    Topalian, Suzanne L.
    Sosman, Jeffrey A.
    Kotapati, Srividya
    Thakkar, Pratik K.
    Ritchings, Corey
    Benito, Melanie Pe
    Re, Sandra
    Soleymani, Samira
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (08) : 938 - 948
  • [28] Ipilimumab combined with stereotactic radiosurgery in melanoma patients with brain metastases: A multicenter, open label, phase 2 trial
    Mortier, Laurent
    Jamme, Philippe
    Lacour, Jean Philippe
    Robert, Caroline
    Lesimple, Thierry
    Thomas, Luc
    Machet, Laurent
    Saiag, Philippe
    Lebbe, Celeste
    Dutriaux, Caroline
    Grob, Jean-Jacques
    Duhamel, Alain
    Desmedt, Eve
    Templier, Carole
    Mirabel, Xavier
    Reyns, Nicolas
    Le Rhun, Emilie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
    Long, Georgina V.
    Atkinson, Victoria
    Lo, Serigne
    Sandhu, Shahneen
    Guminski, Alexander D.
    Brown, Michael P.
    Wilmott, James S.
    Edwards, Jarem
    Gonzalez, Maria
    Scolyer, Richard A.
    Menzies, Alexander M.
    McArthur, Grant A.
    LANCET ONCOLOGY, 2018, 19 (05) : 672 - 681
  • [30] Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
    Margolin, Kim
    Ernstoff, Marc S.
    Hamid, Omid
    Lawrence, Donald
    McDermott, David
    Puzanov, Igor
    Wolchok, Jedd D.
    Clark, Joseph I.
    Sznol, Mario
    Logan, Theodore F.
    Richards, Jon
    Michener, Tracy
    Balogh, Agnes
    Heller, Kevin N.
    Hodi, F. Stephen
    LANCET ONCOLOGY, 2012, 13 (05) : 459 - 465
12345